Attention:

Certain features of Sigma-Aldrich.com will be down for maintenance the evening of Friday August 18th starting at 8:00 pm CDT until Saturday August 19th at 12:01 pm CDT.   Please note that you still have telephone and email access to our local offices. We apologize for any inconvenience.

esiRNA Knockdown Efficiency Tested by Western Blotting

A valuable measure of the knock-down potency of any RNAi experiment is the reduction in protein level. Displayed below are the knock-down rates of  selected esiRNAs using quantitative western blot analysis (Odyssey, Li-COR). The time point for maximum knock-down rate for each protein can vary significantly, as it is depending on factors such as protein stability, turn-over rate or cell proliferation rates. The knock-down validation on protein level was performed at 72 hours post transfection of esiRNA in HeLa cells. To be able to assess knock-down rates, the expression levels of the protein of interest was compared to HeLa cells simultaneously transfected with Renilla Luciferase (negative control). Specific antibodies for the protein of interest were used for the quantitative western blot analysis.

Quantitative Western Blotting

Western blot analyses 72 hours after transfection of HeLa cells with the indicated esiRNAs. Lane 1 contains, a negative control, HeLa cells transfected with Renilla Luciferase esiRNA. Lane 2 includes HeLa cells transfected with the indicated esiRNA. Lysates were separated on SDS-PAGE and probed with the indicated primary antibody. For lanes 1 and 2, the individual esiRNA targets are shown in green while the loading controls are in red. The signal intensities were quantified using an Odyssey infrared imaging system (LI-COR) and normalized to the loading control signal (GAPDH or tubulin).

 

 
  AKT1
OCT4
BCL2
esiRNA EHU083501 EMU081351 EHU135281
Antibody P2482-.2ML
P0082-200UL B3170-.2ML
       
 
  CAT
HSP90 PLK1
esiRNA EHU048671 EHU114671 EHU051011
Antibody C0979-.2ML H1775-.2ML P5998-200UL
       
 
  CAV1 CDK4 ABL1
esiRNA EHU031251 EHU070511 EHU141291
Antibody SAB4200216 C8218-.5ML A5844-.2ML
       
 
  FAS
VCL
CAPN1
esiRNA EHU060231 EHU088101 EHU032581
Antibody F4424-.1ML SAB4200080-200UL C267-100UL
       
   
  KRAS PTEN  
esiRNA EHU114431 EHU106441  
Antibody R3400-.1MG P3487  

 

The reduction in target expression was measured between the negative control RLUC and the sample treated with esiRNA as indicated.

Materials

     
Related Links